Recent drug therapies for corneal neovascularization.

about

Recent drug therapies for corneal neovascularization.

Item

http://www.wikidata.org/entity/Q39295602

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Recent drug therapies for corneal neovascularization.

@en

Recent drug therapies for corneal neovascularization.

@nl

type

Item

label

Recent drug therapies for corneal neovascularization.

@en

Recent drug therapies for corneal neovascularization.

@nl

prefLabel

Recent drug therapies for corneal neovascularization.

@en

Recent drug therapies for corneal neovascularization.

@nl

P1476

Recent drug therapies for corneal neovascularization.

@en

P2093

Jiaming Liang

http://www.w3.org/2001/XMLSchema#string

Shurong Wang

http://www.w3.org/2001/XMLSchema#string

Xuanzhong Wang

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)

Horizons in therapy for corneal angiogenesis.

Regorafenib: A novel tyrosine kinase inhibitor: A brief review of its therapeutic potential in the treatment of metastatic colorectal carcinoma and advanced gastrointestinal stromal tumors

A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab

Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence.

Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.

Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety data.

Anti-angiogenic role of angiostatin during corneal wound healing.

Safety profile of bevacizumab on cultured human corneal cells.

P304

653-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CBDD.13018

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xinyao Liu

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28489275

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization